# Cooperative Study of Factor VIII Inhibitors

> **NCT00000582** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Blood Coagulation Disorders
- Hematologic Diseases
- Hemophilia A
- Hemorrhagic Disorders

## Interventions

- **DRUG:** factor ix

## Key facts

- **NCT ID:** NCT00000582
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1978-07
- **Primary completion:** —
- **Final completion:** 1979-07
- **Target enrollment:** — (—)
- **Last updated:** 2012-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000582, "Cooperative Study of Factor VIII Inhibitors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00000582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*